ArticleFrontiers in oncology2026

Safety and preliminary efficacy of Disitamab Vedotin combined with Toripalimab and concurrent radiotherapy in bladder-preserving treatment for HER2-positive invasive bladder cancer.

Han Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.